Drug profile · INN
allogeneic umbilical cord-derived cd34- cells, non-expanded
ZEMCELPRO
allogeneic umbilical cord-derived cd34- cells, non-expanded (ZEMCELPRO) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Blood and blood forming organs (B05) B05AX04
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — allogeneic umbilical cord-derived cd34- cells, non-expanded
- Class
- Blood and blood forming organs (B05)
- Route
- —
- Patents
- 0
- Programs
- 7
- Data quality
- 0.83
Quick answer
allogeneic umbilical cord-derived cd34- cells, non-expanded (ZEMCELPRO) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN allogeneic umbilical cord-derived cd34- cells, non-expanded
Brand ZEMCELPRO
Therapeutic class Blood and blood forming organs (B05)
ATC code B05AX04
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is allogeneic umbilical cord-derived cd34- cells, non-expanded?
allogeneic umbilical cord-derived cd34- cells, non-expanded (ZEMCELPRO) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for allogeneic umbilical cord-derived cd34- cells, non-expanded?
ZEMCELPRO is a marketed brand name for allogeneic umbilical cord-derived cd34- cells, non-expanded. Check FDA Drugs@FDA for the current US label holder and prescribing information.